Home » Topics » BioWorld Science

BioWorld Science
RSS

Anti-E-selectin antisense compound from Isis inhibits mRNA splicing

Dec. 6, 1996

New analgesic compounds with novel mechanism of action disclosed by Novo Nordisk

Dec. 6, 1996

Cytel announces plans for Cylexin at investors conference

Dec. 5, 1996

Phase II trials begin on low-dose interferon alfa for Sjogren's syndrome

Dec. 5, 1996

Shareholder meeting set to approve Bio-Dental-Zila merger

Dec. 5, 1996

GenPharm generates human anti-IL-8 antibodies

Dec. 5, 1996

New patient-activated drug delivery system from Medtronic released in Europe

Dec. 5, 1996

Moisture-managing foam wound dressing introduced

Dec. 5, 1996

Houghten's lead CRA safe in diabetics

Dec. 5, 1996

Sterinetics System successfully inactivates multiple viruses in IVIg

Dec. 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...